Tweet
<img alt="" height="1" width="1" />
Savient: FDA clears drug for chronic gout
BusinessWeek
Savient Pharmaceuticals Inc. said Tuesday that the US Food and Drug Administration has approved its drug for treating adult patients with a type of chronic gout that doesn't respond well to conventional therapy. The drug, dubbed Krystexxa, ...
The FDA approves new drug for goutLos Angeles Times
FDA Approves Savient Pharma's Gout Drug KrystexxaWall Street Journal
Savient Pharmaceuticals' Krystexxa Approved for GoutBloomberg
RTT News -New York Times (blog) -Arthritis Today
all 46 news articles »
More...